In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a NEOMYCIN SULFATE; POLYMYXIN B SULFATE GRAMICIDIN-2 Drug Master File in Korea (NEOMYCIN SULFATE; POLYMYXIN B SULFATE GRAMICIDIN-2 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of NEOMYCIN SULFATE; POLYMYXIN B SULFATE GRAMICIDIN-2. The MFDS reviews the NEOMYCIN SULFATE; POLYMYXIN B SULFATE GRAMICIDIN-2 KDMF as part of the drug registration process and uses the information provided in the NEOMYCIN SULFATE; POLYMYXIN B SULFATE GRAMICIDIN-2 KDMF to evaluate the safety and efficacy of the drug.
After submitting a NEOMYCIN SULFATE; POLYMYXIN B SULFATE GRAMICIDIN-2 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their NEOMYCIN SULFATE; POLYMYXIN B SULFATE GRAMICIDIN-2 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of NEOMYCIN SULFATE; POLYMYXIN B SULFATE GRAMICIDIN-2 suppliers with KDMF on PharmaCompass.